Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
23,597,628
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1,356,571
-
Shares change
-
+1,356,571
-
Total reported value, excl. options
-
$3,214,622
-
Value change
-
+$3,214,622
-
Number of buys
-
16
-
Price
-
$2.37
Institutional Holders of Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX) as of Q4 2022
As of 31 Dec 2022 Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,356,571 shares of stock of the company.
Largest 10 holders included Alerce Investment Management, L.P., BVF INC/IL, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, GEODE CAPITAL MANAGEMENT, LLC, KCK LTD., RENAISSANCE TECHNOLOGIES LLC, ADVISOR GROUP HOLDINGS, INC., UBS Group AG, and Tower Research Capital LLC (TRC).
This table shows 16 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.